What should we do to optimise outcome in twin pregnancy complicated with placenta percreta? A case report

BMC Pregnancy and Childbirth

Volumn 15, Issue 1, 2015, Pages

  Atalay, Mehmet Aral ^a   Oz Atalay, Fatma ^a   Cetinkaya Demir, Bilge ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Hemorrhage; Infection; Morbidly adherent placenta; Placenta percreta; Twin pregnancy

Indexed keywords

C REACTIVE PROTEIN; CEPHALOSPORIN DERIVATIVE; METHOTREXATE; METRONIDAZOLE;

ABDOMINAL HYSTERECTOMY; ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; CESAREAN SECTION; CURETTAGE; FEMALE; FOLLOW UP; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; INTRAOPERATIVE PERIOD; LEUKORRHEA; PLACENTA ACCRETA; POSTOPERATIVE PERIOD; POSTPARTUM HEMORRHAGE; PRENATAL DIAGNOSIS; PROTEIN BLOOD LEVEL; SPONTANEOUS ABORTION; SURGICAL APPROACH; TISSUE NECROSIS; TREATMENT OUTCOME; TREATMENT PLANNING; TWIN PREGNANCY; ADVERSE EFFECTS; ERYTHROCYTE TRANSFUSION; HYSTERECTOMY; INFECTION; PLASMA; PREGNANCY; PROCEDURES; TIME FACTOR;

CESAREAN SECTION; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; HYSTERECTOMY; INFECTION; PLACENTA ACCRETA; PLASMA; PREGNANCY; PREGNANCY, TWIN; TIME FACTORS;

EID: 84959237611     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/s12884-015-0714-x     Document Type: Article

References (15)

1. Sentilhes L, Ambroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010;115:526-34.
2. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. 1997;177:210-4.
3. Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG. 2014;121:62-70.
4. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107:1226-32.
5. Guy GP, Peisner DB, Timor-Tritsch IE. Ultrasonographic evaluation of uteroplacental blood flow patterns of abnormally located and adherent placentas. Am J Obstet Gynecol. 1990;163:723-7.
6. Nagy PS. Spontaneous rupture of the uterus caused by placenta percreta at 28 weeks of twin pregnancy. Eur J Obstet Gynecol Reprod Biol. 2003;111:207-9.
7. Seow KM, Hwang JL, Tsai YL, Huang LW, Lin YH, Hsieh BC. Subsequent pregnancy outcome after conservative treatment of a previous cesarean scar pregnancy. Acta Obstet Gynecol Scand. 2004;83:1167-72.
8. Topuz S. Spontaneous uterine rupture at an unusual site due to placenta percreta in a 21-week twin pregnancy with previous cesarean section. Clin Exp Obstet Gynecol. 2004;31:239-41.
9. Amsalem H, Kingdom JC, Farine D, Allen L, Yinon Y, D'Souza DL, et al. Planned caesarean hysterectomy versus "conserving" caesarean section in patients with placenta accreta. J Obstet Gynaecol Can. 2011;33:1005-10.
10. Butt K, Gagnon A, Delilse MF. Failure of methotrexate and internal iliac balloon catheterization to manage placenta percreta. Obstet Gynecol. 2002;99:981-2.
11. Papp Z, Tóth-Pál E, Papp C, Sziller I, Gávai M, Silhavy M, et al. Hypogastric artery ligation for intractable pelvic hemorrhage. Int J Gynaecol Obstet. 2006;92:27-31.
12. Provansal M, Courbiere B, Agostini A, D'Ercole C, Boubli L, Bretelle F. Fertility and obstetric outcome after conservative management of placenta accreta. Int J Gynaecol Obstet. 2010;109:147.
13. Sentilhes L, Kayem G, Ambroselli C, Provansal M, Fernandez H, Perrotin F, et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod. 2010;25:2803-10.
14. Zosmer N, Fuller J, Shaikh H, Johns J, Ross JA. The natural history of early first trimester pregnancies implanted in Caesarean scars: a prospective study. Ultrasound Obstet Gynecol. 2015. doi: 10.1002/uog.14775.
15. Committee on Obstetric Practice. ACOG committee opinion no. 529: placenta accreta. Obstet Gynecol. 2012;120:207-11.